Bmi-1 and Sox2 were selected as cell proliferation markers in this study, as they possess similar roles in cell growth (27,29–31), have been implicated in cancer development (32–37) and have not been demonstrated to be affected by melatonin (38). This evidence concerns the gene SOX2 and cancer.